Simultaneous PA + LPS (in vitro) |
Priming |
Enhanced ceramide; enhanced TNF/IL-6 secretion; JNK dependent |
Primary & immortalized mouse macrophages |
Schilling et al., 2013; Jin et al., 2013; Nishiyama et al., 2018
|
PA pre-treatment + LPS (in vitro) |
Trained immunity |
Enhanced TNF/IL-6/IL-1β secretion, all ceramide dependent; role of mitochondria and MAPK signaling |
Primary mouse macrophages; immortalized human & mouse macrophages |
Seufert et al., 2022; Fang et al., 2022; Caslin et al., 2023; Schwartz et al., 2010
|
PA pre-treatment + LPS (in vivo) |
Trained immunity |
Enhanced circulating inflammation; decreased survival |
Wild type female BALB/c mice |
Seufert et al., 2022
|
PA pre-treatment + infection (in vivo) |
Trained immunity |
Enhanced microbial clearance |
Rag−/− mice + Candida albicans infection; wild type female BALB/c mice + Brucella abortus infection |
Seufert et al., 2022; Reyes et al., 2021
|